kabutan

NITTO DENKO CORPORATION(6988) Summary

6988
TSE Prime
NITTO DENKO CORPORATION
3,003.0
JPY
-299.0
(-9.06%)
Apr 28, 3:30 pm JST
18.86
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
2,976
Apr 28, 11:58 pm JST
Summary Chart Historical News Financial Result
PER
14.3
PBR
1.76
Yield
2.13%
Margin Trading Ratio
9.38
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
3,232.0 JPY 20.28 USD
Previous Close Apr 27
3,302.0 JPY 20.71 USD
High Apr 28, 9:00 am
3,234.0 JPY 20.29 USD
Low Apr 28, 2:35 pm
3,001.0 JPY 18.85 USD
Volume
7,933,800
Trading Value
0.02T JPY 0.15B USD
VWAP
3055.08 JPY 19.19 USD
Minimum Trading Value
300,300 JPY 1,886 USD
Market Cap
2.04T JPY 0.01T USD
Number of Trades
11,430
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
5,169
1-Year High Jan 27, 2026
14,427
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 137,300 401,200 2.92
Apr 17, 2026 145,300 365,000 2.51
Apr 10, 2026 134,800 382,800 2.84
Apr 3, 2026 149,100 402,200 2.70
Mar 27, 2026 450,600 482,900 1.07
Company Profile
NITTO DENKO CORPORATION is a comprehensive materials manufacturer specializing in tapes and films. The company produces materials for LCD and semiconductor industries, as well as medical applications, and holds high market shares in niche products.
Sector
Chemicals
NITTO DENKO CORPORATION is a comprehensive materials manufacturer with four main business segments: Industrial Tape, Optronics, Human Life, and New Business. The Industrial Tape segment deals with basic functional materials such as bonding materials, protective materials, and automotive materials. The Optronics segment provides information functional materials like optical films and circuit materials including high-precision substrates. The Human Life segment handles functional films including nucleic acid-related products, polymer separation membranes, and hygiene materials. Through these business segments, the company supplies products to a wide range of fields including electronics, automotive, medical, and life sciences.